Compare · SNX vs WGS
SNX vs WGS
Side-by-side comparison of TD SYNNEX Corporation (SNX) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SNX and WGS operate in Retail: Computer Software & Peripheral Equipment (Technology), so they compete in similar markets.
- SNX is the larger of the two at $21.61B, about 13.9x WGS ($1.55B).
- Over the past year, SNX is up 113.3% and WGS is down 27.8% - SNX leads by 141.0 points.
- SNX has been more active in the news (8 items in the past 4 weeks vs 3 for WGS).
- SNX has more recent analyst coverage (22 ratings vs 8 for WGS).
- Company
- TD SYNNEX Corporation
- GeneDx Holdings Corp.
- Price
- $268.50-3.24%
- $52.31-7.04%
- Market cap
- $21.61B
- $1.55B
- 1M return
- +14.77%
- +51.05%
- 1Y return
- +113.28%
- -27.76%
- Industry
- Retail: Computer Software & Peripheral Equipment
- Retail: Computer Software & Peripheral Equipment
- Exchange
- NYSE
- NASDAQ
- IPO
- 2003
- 2020
- News (4w)
- 8
- 3
- Recent ratings
- 22
- 8
TD SYNNEX Corporation
SYNNEX Corporation provides business process services in the United States and internationally. The company distributes peripherals; and information technology systems, including system components, software, networking, communications and security equipment, consumer electronics, and complementary products, as well as designs and integrates data center equipment. It also provides systems design and integration solutions, build-to-order, and configure-to-order assembly capabilities; logistics services that comprise outsourced fulfillment, virtual distribution, and direct ship to end-users; cloud services; online services; and financing services comprising net terms, third party leasing, floor plan financing, and letters of credit backed financing and arrangements. In addition, the company offers marketing services, such as direct mail, external media advertising, reseller product training, targeted telemarketing campaigns, trade shows, trade groups, database analysis, print on demand services, and web-based marketing. It serves resellers, system integrators, and retailers. The company was formerly known as SYNNEX Information Technologies, Inc. and changed its name to SYNNEX Corporation in October 2003. SYNNEX Corporation was founded in 1980 and is headquartered in Fremont, California.
Latest SNX
- TD SYNNEX to Announce Second Quarter Fiscal 2026 Results on June 25, 2026
- Director Hume Richard T sold $1,401,894 worth of shares (5,000 units at $280.38) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 23,537 units (SEC Form 4)
- SEC Form 8-K filed by TD SYNNEX Corporation
- ConnectSecure Partners with TD SYNNEX to Expand Access to Affordable, Flexible Cybersecurity Worldwide
- SEC Form SD filed by TD SYNNEX Corporation
- TD Synnex upgraded by Analyst with a new price target
- Ramp and TD SYNNEX Partner to Bring Modern Financial Operations to the Global Technology Channel
- Director Hume Richard T sold $1,147,692 worth of shares (5,000 units at $229.54) as part of a pre-agreed trading plan, decreasing direct ownership by 15% to 28,537 units (SEC Form 4)
- Chair, Hyve Solutions Polk Dennis sold $575,937 worth of shares (2,500 units at $230.37) as part of a pre-agreed trading plan (SEC Form 4)
- TD SYNNEX Selected as a HPE Global Distribution Partner
Latest WGS
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 717 shares and sold $19,092 worth of shares (369 units at $51.74), increasing direct ownership by 1.00% to 35,290 units (SEC Form 4) to cover taxes
- GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
- Director Casdin Capital, Llc bought $21,459,736 worth of shares (500,000 units at $42.92) (SEC Form 4)
- Director Meister Keith A. bought $13,765,345 worth of shares (351,273 units at $39.19) (SEC Form 4)
- Director Meister Keith A. bought $46,806,729 worth of shares (1,205,147 units at $38.84) (SEC Form 4)
- SEC Form 4 filed by Director Casdin Capital, Llc
- SEC Form 10-Q filed by GeneDx Holdings Corp.
- GeneDx Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 3,874 shares and sold $141,595 worth of shares (2,172 units at $65.19), increasing direct ownership by 2% to 93,216 units (SEC Form 4) (for tax liability)